General Information
Version
6.6
Revision date
2023-05-24
Product name
3,3′,5,5′-Tetramethylbenzidine
CAS No.
54827-17-7
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H351, H413
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Classification of the substance or mixture GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 4), H302 Carcinogenicity (Category 2), H351 Long-term (chronic) aquatic hazard (Category 4), H413 For the full text of the H-Statements mentioned in this Section, see Section 16
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H351 Suspected of causing cancer. H413 May cause long lasting harmful effects to aquatic life.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 4), H302 Carcinogenicity (Category 2), H351 Long-term (chronic) aquatic hazard (Category 4), H413 For the full text of the H-Statements mentioned in this Section, see Section 16.
